Apheresis technology for prevention and regression of atherosclerosis

Therapeutic Apheresis

Volumn 5, Issue 4, 2001, Pages 221-225

  Yamamoto, Akira ^a,b   Harada Shiba, Mariko ^a   Kawaguchi, Akito ^a   Tsushima, Motoo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b Health Care Facilities for the Aged   (Japan)

Author keywords

Apheresis technology; Atherosclerosis; Cholesterol; Familial hypercholesterolemia

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APHERESIS; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; TECHNOLOGY; TREATMENT OUTCOME;

CORONARY ARTERIOSCLEROSIS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; PLASMAPHERESIS; PYRROLES; TREATMENT OUTCOME;

EID: 0035156864     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00328.x     Document Type: Article

References (21)

1. Forme homozygotes cutaneo-tendineuses des xanthomatose hypercholesterolemique dans une observation familielle exemplaire. Essai de plasmapherese a titre de traitment heroique
2. Improved survival of patients with homozygous familial hypercholesterolemia treated with plasma exchange
3. Assessment of long term plasma exchange for familial hypercholesterolemia
4. LDL-apheresis: Potential procedure for prevention and regression of atheromatous vascular lesion
5. Apheresis technology for prevention and regression of atherosclerosis: An overview
6. A new approach to the management of familial hypercholesterolemia: Removal of plasma cholesterol based on the principle of affinity chromatography
7. Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis (LA-01): Characterization and experimental use for hypercholesterolemic rabbits
8. Improved haemorrheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation
9. DALI apheresis in hyperlipidemic patients: Biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood
10. Treatment of familial hypercholesterolemia by means of specific immunoadsorption
11. Development of immunoadsorbents for apo B-containing lipoprotein apheresis
12. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans
13. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia. A multicenter study
14. Effects of intensive lipid-lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)
15. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia
16. Changes of atherosclerosis of the carotid arteries due to severe familial hypercholesterolemia following long-term plasmapheresis, assessed by duplex scan
17. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
18. Familial hypercholesterolemia regression study: A randomized trial of low-density lipoprotein apheresis
19. LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
20. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
21. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy